Clinical study on circulating blood and extinguishing blood stasis method in acute ischemic stroke patients

급성(急性) 뇌경색환자(腦硬塞患者)에서 활혈화어(活血化瘀) 치법(治法)의 응용(應用)

  • Kim Dong-Woung (Dept. of Internal Medicine, College of Oriental Medicine Wonkwang University)
  • 김동웅 (원광대학교 한의과대학 전주한방병원 내과)
  • Published : 1999.08.29

Abstract

In order to investigate the effect of circulating blood and extinguishing blood stasis method on acute ischemic stroke treatment, we compared muscle weakness in two groups. Dansamhwanotang was administered to experimental group and the Sopungtang was administered to comparison group. In prospective and consecutive study, 24 patients(male 14, female 10) were admitted to hospital within 6hours(median $4.21{\pm}2.45)$ after stroke attack. All of them were diagnosed computed tomography as acute cerebral infarction. We divided that patients into two groups. The experimental group was 13, took median $4.17{\pm}1.72hrs$ to admission after stroke attack and the comparison group 11, median $4.31{\pm}2.72hrs$ to admission after stroke attack. There was no statistical difference in time consumed from stroke onset to admission(P>0.05). Muscle weakness was measured on admission and 7 days later on AMA(American Medical Association) method. In the experimental group, muscle weakness on admission was $2.23{\pm}0.51$ and $2.79{\pm}0.72$ in upper and lower extremity, respectively. In comparison group, muscle weakness on admission was $2.17{\pm}0.43$ and $2.67{\pm}0.82$ in upper and lower extremity, respectively. There was no difference in muscle weakness(P〈0.05). In 7 days after, muscle weakness was $2.31{\pm}0.35$ in upper extremity and $3.15{\pm}0.12$ in lower extremity in experimental group, and $2.27{\pm}0.74$ in upper extremity and $3.45{\pm}0.48$, lower extremity in comparison group. There was no meaningful improvement statistically in upper extremity(p<0.05) but significant evolution in lower extremity(p<0.05). The muscle weakness comparison between admission time and 7 days later was as follows. Experimental group had improvement at the degree of $0.24{\pm}0.92$, $0.42{\pm}0.82$ in upper and lower extremity, respectively and comparison group, $0.12{\pm}0.82$, $0.27{\pm}0.97$ in same part(p<0.05). So, Dansamhwanotang administered group had more good muscle weakness improvement than Sopungtang administered group(P>0.05). From the above result, I suppose that circulating blood and extinguishing blood stasis method helps recover hemiparesis caused by acute ischemic cerabral disease, in acute stage at least.

Keywords

References

  1. 中醫藥 硏究 no.5 活血化瘀의 高血壓性 腦出血 治療 6例에 대한 臨床觀察 徐柏平
  2. 黃帝內經譯解 楊維傑(編)
  3. 遼저中醫雜誌 v.23 no.4 活血化瘀法의 老年 糖尿病 54例 治療 何曉蘭
  4. 中醫硏究 v.9 no.2 活血化瘀法의 糖尿病 慢性 倂發症 治療의 機理 探究 孫愛紅;導師;施賽珠
  5. 中國中醫眼科雜誌 v.6 no.3 滋養肝腎, 活血化瘀藥의 實驗性 糖尿病 大鼠의 視神經組織 狀態에 대한 影響 張發榮;謝學軍;李瑞전;療品正
  6. 江蘇中醫 v.17 no.5 出血性中風 急性期에 活血化瘀法 史用에 대한 是非 高炳英;呂玉珍
  7. 上海中醫藥雜誌 no.11 活血化瘀法의 中風 200例 治療 李蔚生
  8. 東醫寶鑑 許俊
  9. 國譯 醫林改錯 王淸任
  10. 整形外科學 大韓整形學會
  11. 圖解 腦神經外科學 郭隆璘(編)
  12. Stroke v.29 no.7 Risk factor for ischemic stroke ( Dubbo study of the elderly) A.MD, Simons Leon;DPhil, McCallum John;Yechel, Friedlander;Macs, Simon Judith
  13. Stroke v.29 no.1 Stroke risk management Kalra, L.MD
  14. Stroke v.29 no.1 Stroke risk management , Change in mainstream preactice Klalr, L.;Perez, I.;Melbourn, A.
  15. 大韓韓醫學會誌 v.14 no.2 中風患者의 半身痲痺 回復에 대한 臨床的 觀察 高成奎
  16. Cranial MRI and CT, 4/e Lee, S. Howard;Rao, Krishna C.V.G.;Robert, A.
  17. Stroke v.28 no.7 Practice guidelines for the iaging in TIA and acute Stroke Antonio, Culebras;Carlos, Kase;Joseph, Masdeu;Allan, Fox;Nick, Bryan R.;Barrie, Grossman C.
  18. 神經外科學 大韓神經外科學會
  19. 備急千金要方 孫思邈
  20. 王履溯回集(醫部全錄中二十六冊) 王安道
  21. 病因病理學 朴贊國
  22. 雲南中醫中藥雜誌 v.17 no.2 活血化瘀法 實驗 2例 陳愛武
  23. 圖解 鄕藥大事典 鄭普燮;辛民敎
  24. 新編 中藥大辭典 新文豊出版公司(編)
  25. 活血化瘀 硏究新編 姜春茸
  26. 臨床本草學 辛民敎